ProQR Therapeutics (PRQR) Q1 2026 Earnings — Mixed Results

Screener

Reported May 12, 2026 · Before market open

Revenue$2.3MMiss by $2.8M

EPS-$0.15In line

Revenue estimate$5.2M

EPS estimate-$0.15

Next report

Nov 5, 2026 (in 2 months)

Revenue estimate$4.3M

EPS estimate-$0.11

Versus estimates

Revenue

Q2 2026$10.0MBeat by $5.4M

Q1 2026$2.3MMiss by $2.8M

Q4 2025$5.5MMiss by $1.1M Q3 2025$3.4MMiss by $2.7M Q2 2025$4.5MMiss by $997.5K Q1 2025$5.0MBeat by $149.1K

Diluted EPS

Q2 2026-$0.10Beat by $0.03

Q1 2026-$0.15In line

Q4 2025-$0.09Miss by $0.01 Q3 2025-$0.12Miss by $0.02 Q2 2025-$0.14Miss by $0.06 Q1 2025-$0.11Miss by $0.02

FAQ

When did ProQR Therapeutics report Q1 2026 earnings?: ProQR Therapeutics (PRQR) reported Q1 2026 earnings on May 12, 2026 before market open.
What were ProQR Therapeutics's Q1 2026 revenue and EPS?: ProQR Therapeutics reported revenue of $2.3M and eps of $-0.15 for Q1 2026.
Did ProQR Therapeutics beat estimates in Q1 2026?: Revenue missed the consensus estimate of $5.2M by $2.8M. EPS beat the consensus estimate of $-0.15 by $0.00.
How did ProQR Therapeutics's Q1 2026 results compare year-over-year?: Compared to the same quarter a year prior, revenue declined 52.6% from $5.0M a year earlier and eps declined 36.4% from $-0.11.

Ask the moment ProQR Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk